| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO And President
1 company
Mehalick David serves as a CEO And President at COEP. Across recent SEC filings that breaks down to 3 buys and 0 sells. Those positions are worth an estimated $1.9M at current prices.
The biggest single holding is COEP (~$1.9M) as CEO And President. Net of sales, the recent Form 4 record there shows accumulation of 25,054 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2024 | COEP Coeptis Therapeutics Holdings, Inc. | CEO And President | Buy | 25,054 | $0.67 | $16,747.14 | +0.9% | -47.7% | -49.6% |